Literature DB >> 29294420

Formulation and in vitro stability evaluation of ethosomal carbomer hydrogel for transdermal vaccine delivery.

Yibang Zhang1, Weibeng Ng2, Jianguo Hu3, Salma Saleh Mussa3, Yanru Ge3, Huaxi Xu4.   

Abstract

The primary objective of this study was to develop, evaluate and compare the effectiveness and stability of ethosomal carbomer gels in different solvents. The optimal ethosomal formulation was isolated to create ethosomal gels using carbomer in either pure water (water gel) or PBS containing 30% ethanol (PBS gel). In vitro release of the ethosomal gels were tested using Franz apparatus on hydrophilic and hydrophobic artificial membranes. In vitro stability of two ethosomal gels was systematically evaluated. Transdermal antigen delivery of ethosomal gel was finally performed on the skin of hair removal mice. Both solvent and concentration effects on the in vitro release performance of ethosomal gel of carbomer have been confirmed. Penetration depth has been found to be dependent on the nature of the membranes such that penetration rate is higher in the hydrophobic membrane than the hydrophilic ones. Furthermore, in vitro stability test indicated that ethosomal PBS gel was more stable than ethosomal water gel. In vivo immunoassay confirmed that the ethosomal PBS gel could deliver the antigenic molecules into the skin of mice and stimulate specific IgG secretion. Using the same solvent for lipid vesicular formulation when making polymeric hydrogel may help to provide a more conducive environment for lipid vesicles and hence enhance their roles in transdermal antigen delivery.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Carbomer; Ethosomes; Hydrogel; Rheology; Transdermal vaccination

Mesh:

Substances:

Year:  2017        PMID: 29294420     DOI: 10.1016/j.colsurfb.2017.12.031

Source DB:  PubMed          Journal:  Colloids Surf B Biointerfaces        ISSN: 0927-7765            Impact factor:   5.268


  7 in total

1.  Flexible liposomal gel dual-loaded with all-trans retinoic acid and betamethasone for enhanced therapeutic efficiency of psoriasis.

Authors:  Wei Wang; Gao-Feng Shu; Kong-Jun Lu; Xiao-Ling Xu; Min-Cheng Sun; Jing Qi; Qiao-Ling Huang; Wei-Qiang Tan; Yong-Zhong Du
Journal:  J Nanobiotechnology       Date:  2020-05-24       Impact factor: 10.435

2.  Rethinking Breast Cancer Chemoprevention: Technological Advantages and Enhanced Performance of a Nanoethosomal-Based Hydrogel for Topical Administration of Fenretinide.

Authors:  Alexsandra Conceição Apolinário; Giovanna Cassone Salata; Marcelo Medina de Souza; Marlus Chorilli; Luciana Biagini Lopes
Journal:  AAPS PharmSciTech       Date:  2022-04-05       Impact factor: 3.246

Review 3.  The Importance of Nanocarrier Design and Composition for an Efficient Nanoparticle-Mediated Transdermal Vaccination.

Authors:  Rayen Yanara Valdivia-Olivares; Maria Rodriguez-Fernandez; María Javiera Álvarez-Figueroa; Alexis M Kalergis; José Vicente González-Aramundiz
Journal:  Vaccines (Basel)       Date:  2021-12-01

4.  Hyaluronan-modified transfersomes based hydrogel for enhanced transdermal delivery of indomethacin.

Authors:  Ming Yuan; Jiangxiu Niu; Qinghan Xiao; Huiyuan Ya; Yansong Zhang; Yanli Fan; Lingmei Li; Xueke Li
Journal:  Drug Deliv       Date:  2022-12       Impact factor: 6.419

5.  Agarose Stearate-Carbomer940 as Stabilizer and Rheology Modifier for Surfactant-Free Cosmetic Formulations.

Authors:  Qiong Xiao; Guo Chen; Yong-Hui Zhang; Fu-Quan Chen; Hui-Fen Weng; An-Feng Xiao
Journal:  Mar Drugs       Date:  2021-06-16       Impact factor: 5.118

Review 6.  Lipid-Based Nanovesicular Drug Delivery Systems.

Authors:  Tania Limongi; Francesca Susa; Monica Marini; Marco Allione; Bruno Torre; Roberto Pisano; Enzo di Fabrizio
Journal:  Nanomaterials (Basel)       Date:  2021-12-14       Impact factor: 5.076

7.  Anti-inflammatory ethosomal nanoformulation in combination with iontophoresis in chronic wound healing: An ex vivo study.

Authors:  Reza Mombeiny; Shima Tavakol; Mostafa Kazemi; Mehdi Mehdizadeh; Akbar Hasanzadeh; Mohammad Karimi Babaahmadi; Ali Abedi; Peyman Keyhanvar
Journal:  IET Nanobiotechnol       Date:  2021-10-18       Impact factor: 1.847

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.